The journey of vaccine development has evolved dramatically since Edward Jenner's accidental discovery of the smallpox vaccine in 1796. At that time, the scientific understanding of viruses was rudimentary, and Jenner's success relied on the cross-protection provided by cowpox. Early methods for preserving vaccines were labor-intensive. Vaccines needed to be continuously rederived, often requiring arm-to-arm transmission to keep them viable. Over time, advances such as glycerin preservation in the 1890s and freeze-drying techniques in the 1940s improved the reliability and reach of vaccinations, culminating in the smallpox eradication in the 1960s. Louis Pasteur built on Jenner’s foundation by developing vaccines for other diseases, notably rabies and anthrax, through systematic experimentation. His methods involved attenuating pathogens and inactivating them with heat or chemicals, paving the way for safer vaccination practices. Pasteur's breakthrough in rabies vaccines came through a series of animal experiments, which ultimately led to successful treatments for humans bitten by rabid animals. Meanwhile, Robert Koch revolutionized microbial cultivation by introducing solid media with agar, allowing clearer observation and research in vaccine development. The 20th century brought further breakthroughs with the ability to culture animal cells, crucial for developing vaccines against viral diseases like polio. Techniques like Ross Harrison's hanging drop method in 1907 and advancements in cell culture methods transformed vaccine research. By the 1920s, scientists were isolating and propagating cells, which enabled the growth of the poliovirus in lab settings. These advances, combined with improved safety measures like antibiotics, have set the stage for the current golden age of vaccine development, where vaccines can be designed in weeks to combat emerging pathogens.